Latest News

(UroToday.com) At the Society of Urologic Oncology (SUO) Summer Virtual Webcast, Dr. Bishoy Faltas from Weill Cornell compared the genetic components of the bladder and upper tract urothelial carcinoma. Upper tract urothelial carcinoma comprises 5-10% of all urothelial carcinomas with a unique epidemiologic association with Arsenic exposure and aristolochic acid. Upper tract urothelial carcinoma presents […]

(UroToday.com) The Society of Urologic Oncology held a virtual meeting on Saturday, July 18, 2020, in place of the usual meeting held at the American Urological Association annual meeting. This virtual meeting was divided into sessions on bladder cancer, kidney cancer, and prostate cancer. In the session on kidney cancer, Ashkan Malayeri, MD, presented an “Update […]

(UroToday.com) The Society of Urologic Oncology held a virtual meeting on Saturday, July 18, 2020 in place of the usual meeting held at the American Urological Association annual meeting. This virtual meeting was divided into sessions on bladder cancer, kidney cancer, and prostate cancer. In the session on prostate cancer, Dr. Laurence Klotz discussed the […]

(UroToday.com) In this interesting debate, Dr. Tsaur presented a case of a 63-year-old man who initially underwent robotic radical prostatectomy with pathology showing a pT3bN0M0 Gleason 7 disease with an initial PSA of 18 ng/ml.

(UroToday.com) The Society of Urologic Oncology (SUO) held a virtual meeting on Saturday, July 18, 2020, in place of the usual meeting held at the American Urological Association (AUA) Annual Meeting. This virtual meeting was divided into sessions on bladder cancer, kidney cancer, and prostate cancer. In the session on prostate cancer, Dr. Keith Kowalczyk presented […]

(UroToday.com) Outcomes of immunotherapy have been the highlight of meetings over the last decade. At the 2020 European Association of Urology (EAU) Virtual Meeting, Dr. Yohann Loriot discussed novel treatment options beyond immunotherapy. As noted by Dr. Loriot, the vast majority of trials with new drugs are investigating immunotherapy, but a better understanding of the tumor […]

To examine whether the school toilet environment at age 13, including bullying at toilets, is associated with female LUTS at ages 13 and 19, as little is known about the association among school toilet environment, voiding behaviors, and lower urinary tract symptoms (LUTS) in adolescent girls.

Overactive bladder (OAB) is a prevalent disorder that increases with age and impairs patients’ quality of life. Guidelines recommend behavior modifications as the first-line treatment; however, physiotherapy has also been used with success, safety, and low cost.

Sacral nerve stimulation (SNS) is widely used to treat refractory idiopathic overactive bladder (OAB) and idiopathic urinary retention. However, clinical outcomes are variable and understanding predictive factors for success or side-effects would enable personalization of therapy and optimization of outcomes.

Overactive bladder (OAB) is a medical condition characterized by an increase frequency and urgency, with or without urge incontinence. 80% of the world’s population presently uses herbal medicine for some aspect of primary health care according to a survey conducted by World Health Organization.